Suppr超能文献

阿米替林和拉莫三嗪治疗创伤性脊髓损伤所致神经性疼痛的疗效:一项随机纵向对照研究。

Effectiveness of amitriptyline and lamotrigine in traumatic spinal cord injury-induced neuropathic pain: a randomized longitudinal comparative study.

作者信息

Agarwal N, Joshi M

机构信息

Physical Medicine and Rehabilitation, Sawai Man Singh Medical College and Hospital, Jaipur, India.

Department of PMR, SMS Medical College & Associate Hospital Jaipur, Jaipur, India.

出版信息

Spinal Cord. 2017 Feb;55(2):126-130. doi: 10.1038/sc.2016.123. Epub 2016 Aug 16.

Abstract

STUDY DESIGN

Randomized longitudinal comparative study.

OBJECTIVES

To compare the efficacy of lamotrigine and amitriptyline in the management of traumatic spinal cord injury (SCI)-induced neuropathic pain (NP).

SETTING

Sawai Man Singh Medical College and Hospital, Jaipur, India.

METHODS

A total of 147 individuals with NP were randomized for a 3-week trial of either amitriptyline or lamotrigine. Amitriptyline was administered orally at doses of 25, 50 and 100 mg once daily at night time, and lamotrigine was administered orally at doses of 25, 50 and 100 mg twice daily, both for 1 week by means of optional titration. Assessment of NP was done at baseline and thereafter at 1, 2 and 3 weeks using Short-form MC Gill Pain Questionnaire-2 (SFMPQ2) scores.

RESULTS

There was a significant difference between the mean values of the SFMPQ2 score at baseline and those at each follow-up for amitriptyline. Similar results were seen in the lamotrigine group. When the differences in mean SFMPQ2 scores at different time frames from baseline were compared with those of the other group, values were found to be nonsignificant as seen on the Mann-Whitney U-test.

CONCLUSIONS

These findings support the use of both amitriptyline and lamotrigine in the management of NP after traumatic SCI.

摘要

研究设计

随机纵向比较研究。

目的

比较拉莫三嗪和阿米替林治疗创伤性脊髓损伤(SCI)所致神经性疼痛(NP)的疗效。

地点

印度斋浦尔的萨瓦伊·曼·辛格医学院及医院。

方法

总共147名患有NP的个体被随机分配,进行为期3周的阿米替林或拉莫三嗪试验。阿米替林于夜间口服,剂量分别为25、50和100毫克,每日一次;拉莫三嗪口服,剂量分别为25、50和100毫克,每日两次,两者均通过可选滴定法给药1周。使用简短麦吉尔疼痛问卷-2(SFMPQ2)评分在基线时以及之后的第1、2和3周对NP进行评估。

结果

阿米替林组基线时与每次随访时的SFMPQ2评分均值之间存在显著差异。拉莫三嗪组也有类似结果。当将不同时间点相对于基线的SFMPQ2评分均值差异与另一组进行比较时,经曼-惠特尼U检验发现差异无统计学意义。

结论

这些发现支持阿米替林和拉莫三嗪均可用于治疗创伤性SCI后的NP。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验